Non-Executive Chairman

Elmar Schnee was CEO of Cardiorentis in Zug, Switzerland from 2011–2013. Prior to this Elmar was the General Partner and member of the Executive Board of Merck KGaA, responsible for its worldwide pharmaceutical business in Rx and OTC with sales of € 6 Billion and 18’000 employees until June 2011. He also led the major restructuring of the business in acquiring Serono for € 10.3 billion and selling the Generic Division for € 4.9 billion. As CEO, he led the successful integration into Merck Serono until end of 2010. Prior to Merck, Elmar held senior roles in Marketing, Strategy and Business Development in UCB Brussels, Sanofi-Synthelabo in Paris, Migliara Kaplan in Baltimore and Fisons in UK.